July 03, 2009
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for March 27, 2005 Subscribe to this News Feed  
 

A Website Dedicated to Providing Pain Relief Information and Pain Relief Products for the Effective Treatment of Postherpetic Neuralgia (PHN) Shingles Disease

Post-herpetic Neuralgia (PHN) is a debilitating, life-altering condition. PHN is a nerve inflammation that remains or intensifies after the shingles rash resolves. Three distinct types of pain are associated with Postherpetic Neuralgia: steady burning pain, episodic pain and pain on stimulation of the skin. Most studies of treatment for postherpetic neuralgia indicate that total relief of pain symptoms is rarely achieved and most patients report significant side effects from the analgesic or antidepressant medications studied. http://www.shinglespainreliefforpain.com was founded as a new web site that pulls together the current existing fragmented informational environment by identifying and offering detailed information on Postherpetic Neuralgia (a very painful condition arising from the Shingles Disease), pain relief treatment, products, and pain management for a host of medical problems arising from Postherpetic Neuralgia (PHN).

(PRWEB) March 27, 2005 -- Postherpetic Neuralgia is caused by nerve damage from the Shingles Disease. PHN is basically a very painful post Shingles Disease lifestyle of extremely painful episodes that can continue long after the rash from shingles heals.

Shingles, or herpes zoster, is caused by the varicella zoster virus (VZV), the same one that gives rise to chickenpox - a finding confirmed as late as the 1950s.

It is estimated that anywhere from 600,000 to 1,000,000 cases of shingles occur annually in the United States, with approximately 5% of the cases being repeat episodes.

Everyone who's had chickenpox - about nine out of ten adults - is at risk of developing shingles. In fact, only about 10-20% of the US population will contract the disease at some point in their lives, but it is more common in the elderly and those who are immunocompromised.

  • lifetime odds of getting shingles are one-in-five.

  • about 1-in-20 patients who have shingles and recover will get it again later on.

Approximately 10 percent of cases of herpes zoster infection (Shingles) results in significant Postherpetic Neuralgia (PHN). The incidence of Postherpetic Neuralgia rises dramatically with age, with over one half of all cases of herpes zoster in patients older than 60 years resulting in this end- stage disorder.

Three distinct types of pain are associated with Postherpetic Neuralgia:

  • steady burning pain,
  • episodic pain and,
  • pain on stimulation of the skin.

Postherpetic Neuralgia (PHN) becomes permanent or persists for many years in about 50% of those affected, THERE IS NO KNOWN CURE, and most cases are difficult to treat when it comes to achieving meaningful pain relief.

Although Shingles may disappear within a couple of weeks, PHN is a severe pain that may continue for several months or even years.

Post-herpetic neuralgia (PHN) is THE MAJOR PROBLEM with SHINGLES. It occurs in up to 50 per cent of those affected.

PHN is probably caused by damage to the nerve cells in the brain at the time of the attack of shingles, and can lead to increased sensitivity of the affected area to ordinary stimuli like light touch. It can also cause permanent pain in the area.

Postherpetic Neuralgia pain is difficult to treat. Once PHN develops, a multidisciplinary approach that involves a pain specialist, psychiatrist, primary care physician, and other health-care providers may provide the best means to relieve the pain and distress associated with this condition.

Most studies of treatment for postherpetic neuralgia indicate that total relief of pain symptoms is rarely achieved and most patients report significant side effects from the analgesic or antidepressant medications studied.

This is the reason why at Pain Relief for Pain Inc., we decided to develop a new web site http://www.shinglespainreliefforpain.com to offer pain relief information and pain relief alternatives to those who will suffer and currently suffer from this very painful disease.

The purpose of this web site is to consolidate information about PHN pain relief and PHN pain relief products that have proven pain relief effective for Postherpetic Neuralgia (PHN) as associated with the Shingles disease but are not invasive in nature...that is...every product on this web site deals with PHN pain as either an external application applied pain remedy or taken by mouth as with pills but are Nnot additive.

Pain products that are addictive or delivered by an intravenous method such as from a hypodermic needle are not supported as remedies but are informationally addressed on the site.

http://www.shinglespainreliefforpain.com is about Preventing Pain, Pain information, Pain Management and Pain Relief Products as associated with PHN, not addictive products that, while effective in the beginning, become addictive over time and cause more problems than they solve.

Four products are currently offered on the web site as clinically tested, testimonial proven temporary pain relief efficacy solutions for PHN pain relief.

  • MENASTIL
  • EZ PAIN RELIEF
  • 024
  • VITAL REMEDY

For additional information please contact:

Ray Attebery
President
Empowered Media Corp.
d.b.a. Pain Relief for Pain Inc.
Off: 212-594-5351 Ext #16
Cell: 267-372-2371
http://www.shinglespainreliefforpain.com

###


See the original story at: http://www.prweb.com/releases/2005/03/prweb221537.htm
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
Ray Attebery
Pain Relief for Pain Inc.
267-372-2371
Email us Here

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright